Cooper Completes Viatris Deal After Agreeing To Offload Brands

Cooper Consumer Health has closed its acquisition of Viatris' OTC business as it commits to divesting the rights to infant laxative medicine Bebegel and earwax removal product Otowaxol in certain markets.

• Source: Shutterstock

Cooper Consumer Health has completed its acquisition of Viatris’ OTC business after agreeing to offload two brands to allay competition concerns.

More from Deals

More from Business